|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-10-20
|
|
pubmed:abstractText |
Anti-tumor necrosis factor alpha (anti-TNF- alpha ) antibodies have been used for the treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA) and psoriasis arthritis. Such antibody therapies result in a severe interference with the patient's immune system. Increased rates of upper respiratory tract infection, reactivation of latent tuberculosis, and other systemic infectious diseases have been reported among patients receiving anti-TNF- alpha antibodies.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e88-94
|
|
pubmed:meshHeading |
pubmed-meshheading:15494900-Antibodies, Monoclonal,
pubmed-meshheading:15494900-Antiviral Agents,
pubmed-meshheading:15494900-Arthritis, Rheumatoid,
pubmed-meshheading:15494900-Cytomegalovirus Retinitis,
pubmed-meshheading:15494900-Female,
pubmed-meshheading:15494900-Ganciclovir,
pubmed-meshheading:15494900-Humans,
pubmed-meshheading:15494900-Middle Aged,
pubmed-meshheading:15494900-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis.
|
|
pubmed:affiliation |
Division of Infectious Diseases and Clinical Immunology, Third Department of Internal Medicine, University Hospital Ulm, Germany.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
